Bill > HR2286

This bill, known as the "American Genetic Privacy Act of 2025," aims to prevent the sale or disclosure of genetic information to the People's Republic of China (PRC) or entities under its control. Specifically, the bill prohibits individuals, entities, and commercial DNA testing services from selling or sharing "covered information" (genetic information originally acquired through DNA testing services) with the PRC or PRC-controlled entities. Commercial DNA testing services are defined as providers of genealogical or ancestry-related information based on an individual's DNA. The Federal Trade Commission (FTC) would be responsible for enforcing these provisions, treating violations as unfair or deceptive practices under existing FTC regulations. The bill draws its definition of "genetic test" from the Genetic Information Nondiscrimination Act of 2008, ensuring a consistent legal framework. Violations would be subject to penalties outlined in the Federal Trade Commission Act, effectively creating a legal mechanism to prevent the transfer of sensitive genetic data to the PRC, which could potentially be used for surveillance, research, or other purposes deemed harmful to national interests.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/2286/all-info